Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor (NNRTI) used worldwide as part of combination antiretroviral therapy in infants and children to treat HIV infection. Dosing based on either weight or body surface area has been approved by the U.S. Food and Drug Administration (FDA)...
Saved in:
Main Authors: | Nikanjam M., Kabamba D., Cressey T.R., Burger D., Aweek F.T., Acosta E.P., Spector S.A., Capparelli E.V. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84866307391&partnerID=40&md5=435c12d5ef62d0f7bc94e03ad2863b54 http://cmuir.cmu.ac.th/handle/6653943832/908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
by: Mina Nikanjam, et al.
Published: (2018) -
Developmental pharmacokinetic changes of lamivudine in infants and children
by: Tremoulet A.H., et al.
Published: (2014) -
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand
by: Vanprapar N., et al.
Published: (2014)